§ Mr. DalyellTo ask the Secretary of State for Health what evaluation has been made of Di Hydrase Testosterone as a medicine for diseased prostates.
§ Mrs. Virginia BottomleySection 118 of the Medicines Act 1968 precludes the disclosure of information relating to product licence applications of their subsequent progress through the licencsing system.
Before any new drug can be licensed in the United Kingdom it is evaluated in the first instance by the Committee on Safety of Medicines for its safety, efficacy and quality for the purposes set out in the product licence application.